Abel
T, Nguyen PV, Barad M, Deuel TA, Kandel ER and Bourtchouladze R.
Genetic demonstration of a role for PKA in the late phase of LTP and in
hippocampus-based long-term memory. Cell 88: 615-626, 1997.
Aggleton
JP and Brown MW. Episodic memory, amnesia, and the hippocampal-anterior thalamic
axis. Behav.Brain Sci. 22: 425-444, 1999.
Aguayo
LG, Peoples RW, Yeh HH and Yevenes GE. GABA
(A) receptors as molecular sites of ethanol action. Direct or indirect actions?
Curr
Top Med Chem. 2:869-885, 2002.
Al
Ghoul WM, Herman MD and Dubocovich ML. Melatonin receptor subtype expression in
human cerebellum. Neuroreport 9: 4063-4068, 1998.
Andersen
P, Bliss TV and Skrede KK. Unit analysis of hippocampal population spikes.
Exp.Brain Res. 13: 208-221, 1971.
Anis
Y, Nir I and Zisapel N. Diurnal variations in melatonin binding sites in the
hamster brain: impact of melatonin. Mol.Cell Endocrinol. 121-129, 1989.
Anton-Tay
F, Ramirez G, Martinez I and Benitez-King G. In vitro stimulation of
protein kinase C by melatonin. Neurochem.Res. 23: 601-606, 1998.
Arendt
J. Melatonin, circadian rhythms, and sleep. N.Engl.J.Med. 343: 1114-1116, 2000.
Arendt
J and Broadway J. Light and melatonin as zeitgebers in man. Chronobiol.Int. 4:
273-282, 1987.
Arendt
J, Deacon S, English J, Hampton S and Morgan L. Melatonin and adjustment to
phase shift. J.Sleep Res. 4: 74-79, 1995.
Arushanian
EB and Beier EV. The participation
of the dorsal hippocampus in the antianxiety action of melatonin and diazepam.
Eksp.Klin.Farmakol. 61: 13-16, 1998.
Avshalumov
MV and Rice ME. NMDA
receptor activation mediates hydrogen peroxide-induced pathophysiology in rat
hippocampal slices. J
Neurophysiol. 87:2896-2903, 2002.
Axelrod
J, Quay WB and Baker PC. Enzymatic synthesis of the skin-lightening agent,
melatonin, in amphibians. Nature 208: 386, 1965.
Axelrod
J, Snyder SH, Heller A and Moore RY. Light-induced changes in pineal
hydroxyindole-O-methyltransferase: abolition by lateral hypothalamic lesions.
Science 154: 898-899, 1966.
Bach
ME, Hawkins RD, Osman M, Kandel ER and Mayford M. Impairment of spatial but not
contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP
in the range of the theta frequency. Cell 81: 905-915, 1995.
Barnes
CA. Involvement of LTP in memory: are we searching under the street light?
Neuron 15:751-754, 1995.
Barrett
P, Davidson G, Hazlerigg DG, Morris MA, Ross AW and Morgan PJ. Mel 1a melatonin
receptor expression is regulated by protein kinase C and an additional pathway
addressed by the protein kinase C inhibitor Ro 31-8220 in ovine pars tuberalis
cells. Endocrinology 139: 163-171, 1998.
Baskys
A and Malenka RC. Agonists at metabotropic glutamate receptors presynaptically
inhibit EPSCs in neonatal rat hippocampus. J.Physiol 444: 687-701, 1991.
Bekkers
JM and Stevens ChF. Presynaptic
mechanism for long-term potentiation in the hippocampus.
Nature 346:724-729, 1990.
Benitez-King
G and Anton-Tay F. Calmodulin mediates melatonin cytoskeletal effects.
Experientia 49: 635-641, 1993.
Benitez-King
G, Hernandez ME, Tovar R and Ramirez G. Melatonin activates PKC-alpha but not
PKC-epsilon in N1E-115 cells. Neurochem.Int. 39: 95-102, 2001.
Benitez-King
G, Huerto-Delgadillo L and Anton-Tay F. Melatonin modifies calmodulin cell
levels in MDCK and N1E-115 cell lines and inhibits phosphodiesterase activity in
vitro. Brain Res. 557: 289-292, 1991.
Benitez-King
G, Huerto-Delgadillo L and Anton-Tay F. Binding of 3H-melatonin to calmodulin.
Life Sci. 53: 201-207, 1993.
Benitez-King
G, Rios A, Martinez A and Anton-Tay F. In vitro inhibition of
Ca2+/calmodulin-dependent kinase II activity by melatonin. Biochim.Biophys.Acta
1290: 191-196, 1996.
Bennett
JP and Snyder SH. Stereospecific binding of D-lysergic acid diethylamide (LSD)
to brain membranes: relationship to serotonin receptors. Brain Res. 94: 523-544,
1975.
Benson
B and Krasovich M. Circadian rhythm in the number of granulated vesicles in the
pinealocytes of mice. Effects of sympathectomy and melatonin treatment. Cell
Tissue Res. 184: 499-506, 1977.
Beresford
IJ, Browning C, Starkey SJ, Brown J, Foord SM, Coughlan J, North PC, Dubocovich
ML and Hagan RM. GR196429: a nonindolic agonist at high-affinity melatonin
receptors. J.Pharmacol.Exp.Ther. 285: 1239-1245, 1998.
Bittman
EL, Karsch FJ and Hopkins JW. Role of the pineal gland in ovine photoperiodism:
regulation of seasonal breeding and negative feedback effects of estradiol upon
luteinizing hormone secretion. Endocrinology 113: 329-336, 1983.
Bittman
EL and Weaver DR. The distribution of melatonin binding sites in neuroendocrine
tissues of the ewe. Biol.Reprod. 43: 986-993, 1990.
Bliss
TV and Lomo T. Long-lasting potentiation of synaptic transmission in the dentate
area of the anaesthetized rabbit following stimulation of the perforant path.
J.Physiol 232: 331-356, 1973.
Blumenau
C, Berger E, Fauteck JD, Madeja M, Wittkowski W, Speckmann EJ and Musshoff U.
Expression and functional characterization of the mt1 melatonin receptor from
rat brain in Xenopus oocytes: evidence for coupling to the phosphoinositol
pathway. J.Pineal Res. 30: 139-146, 2001.
Bordt
SL, McKeon RM, Li PK, Witt-Enderby PA and Melan MA.
N1E-115
mouse neuroblastoma cells express MT1 melatonin receptors and produce neurites
in response to melatonin. Biochim
Biophys Acta 1499:257-264, 2001.
Borjigin
J, Li X and Snyder SH. The pineal gland and melatonin: molecular and
pharmacologic regulation. Annu.Rev.Pharmacol.Toxicol. 39: 53-65, 1999.
Brinklow
BR and Loudon AS. Evidence for a circannual rhythm of reproduction and prolactin
secretion in a seasonally breeding macropodid marsupial, the Bennett's wallaby (Macropus
rufogriseus rufogriseus). J.Reprod.Fertil. 98: 625-630, 1993.
Brodkin
J. Assessing memory in mice using
habituation of nose-poke responding. Behav. Pharmacol.10:445-451, 1999.
Brown
P and Dale N. Modulation
of K(+) currents in Xenopus spinal neurons by p2y receptors: a role for ATP and
ADP in motor pattern generation. J
Physiol. 540:843-850, 2002.
Brusco
LI, Garcia-Bonacho M, Esquifino AI and Cardinali DP. Diurnal rhythms in
norepinephrine and acetylcholine synthesis of sympathetic ganglia, heart and
adrenals of aging rats: effect of melatonin. J.Auton.Nerv.Syst. 74: 49-61, 1998.
Brzezinski
A. Melatonin in health and disease. Fertil.Steril. 55: 1025, 1991.
Bubenik,
G. A., Niles, L. P., Pang, S. F., and Pentney, P. J. Diurnal variation and
binding characteristics of melatonin in the mouse brain and gastrointestinal
tissues. Comp Biochem.Physiol C. 104: 221-224, 1993.
Buonomano
DV, Merzenick MM. Transformation of
temporal information into a spatial code by a neural network based on realistic
neuronal properties. Science 267:1028-1031, 1995.
Burkhardt
S, Reiter RJ, Tan DX, Hardeland R, Cabrera J and Karbownik M. DNA oxidatively
damaged by chromium(III) and H(2)O(2) is protected by the antioxidants
melatonin, N(1)-acetyl-N(2)-formyl-5- methoxykynuramine, resveratrol and uric
acid. Int.J.Biochem.Cell Biol. 33: 775-783, 2001.
Buzsaki
G. Feed-forward inhibition in the
hippocampal formation. Progr Neurobiol 22:131-153, 1984.
Cabrera
J, Reiter RJ, Tan DX, Qi W, Sainz RM, Mayo JC, Garcia JJ, Kim SJ and El Sokkary
G. Melatonin reduces oxidative neurotoxicity due to quinolinic acid: in vitro
and in vivo findings. Neuropharmacology 39: 507-514, 2000.
Cagnacci
A, Soldani R and Yen SS. The effect of light on core body temperature is
mediated by melatonin in women. J.Clin.Endocrinol.Metab 76: 1036-1038, 1993.
Cahill
GM. Circadian regulation of melatonin production in cultured zebrafish pineal
and retina. Brain Res. 708: 177-181, 1996.
Cahill
GM and Besharse JC. Retinal melatonin is metabolized within the eye of xenopus
laevis. Proc.Natl.Acad.Sci.U.S.A 86: 1098-1102, 1989.
Camacho
J and Sanchez JA. Inactivation
of I(A) channels of frog skeletal muscle is modulated by ATP.
Biochem
Biophys Res Commun. 291:1287-1292, 2002.
Cantrell
AR, Tibbs VC, Westenbroek RE, Scheuer T and Catterall WA. Dopaminergic
modulation of voltage-gated Na+ current in rat hippocampal neurons requires
anchoring of cAMP-dependent protein kinase.
J Neurosci. 19:RC21, 1999.
Cardinal
RN, Parkinson JA, Hall J and Everitt BJ. Emotion
and motivation: the role of the amygdala, ventral striatum, and prefrontal
cortex. Neurosci
Biobehav Rev. 26:321-352, 2002.
Cardinali
DP, Golombek DA, Rosenstein RE, Cutrera RA and Esquifino AI. Melatonin site and
mechanism of action: single or multiple? J.Pineal Res. 23: 32-39, 1997.
Cardinali
DP, Vacas MI and Boyer EE. Specific binding of melatonin in bovine brain.
Endocrinology 105: 437-441, 1979.
Carlson
LL, Weaver DR and Reppert SM. Melatonin signal transduction in hamster brain:
inhibition of adenylyl cyclase by a pertussis toxin-sensitive G protein.
Endocrinology 125: 2670-2676, 1989.
Carter
AG, Vogt KE, Foster KA and Regehr WG. Assessing
the role of calcium-induced calcium release in short-term presynaptic plasticity
at excitatory central synapses. J
Neurosci 22:21-28, 2002.
Cazevieille
C and Osborne NN. Retinal neurones containing kainate receptors are influenced
by exogenous kainate and ischaemia while neurones lacking these receptors are
not -- melatonin counteracts the effects of ischaemia and kainate. Brain Res.
755: 91-100, 1997.
Cazevieille
C, Safa R and Osborne NN. Melatonin protects primary cultures of rat cortical
neurones from NMDA excitotoxicity and hypoxia/reoxygenation. Brain Res. 768:
120-124, 1997.
Chen
Y, Chad JE and Wheal HV. Synaptic
release rather than failure in the conditioning pulse results in paired-pulse
facilitation during minimal synaptic stimulation in the rat hippocampal CA1
neurones. Neurosci
Lett 218:204-208, 1996.
Christie
BR and Abraham W. Differential
regulation of paired-pulse plasticity following LTP in the dentate gyrus.
Neuroreport 5:385-388, 1994.
Chu
GH, Witt-Enderby PA, Jones M and LI PK. Synthesis and Pharmacological Analysis
of High Affinity Melatonin Receptor Ligands. Chem. Pharm. Bull. 50:272-275,
2002.
Chuang
TT, LeVine H and De Blasi A. Phosphorylation and activation of beta-adrenergic
receptor kinase by protein kinase C. J.Biol.Chem. 270: 18660-18665, 1995.
Ciesla
W. Can melatonin regulate the expression of prohormone convertase 1 and 2 genes
via monomeric and dimeric forms of RZR/ROR nuclear receptor, and can melatonin
influence the processes of embryogenesis or carcinogenesis by disturbing the
proportion of cAMP and cGMP concentrations? Theoretic model of controlled
apoptosis. Med.Hypotheses 56: 181-193, 2001.
Cohen
M, Roselle D, Chabner B, Schmidt TJ and Lippman M. Evidence for a cytoplasmic
melatonin receptor. Nature 274: 894-895, 1978.
Collingridge
GL, Kehl SJ and McLennan H. The antagonism of amino acid-induced excitations of
rat hippocampal CA1 neurones in vitro. J.Physiol 334: 19-31, 1983.
Collins
DR and Davies SN. Melatonin blocks the induction of long-term potentiation in an
N-methyl- D-aspartate independent manner. Brain Res. 767: 162-165, 1997.
Coloma
FM and Niles LP. Melatonin enhancement of [3H]-gamma-aminobutyric acid and
[3H]muscimol binding in rat brain. Biochem.Pharmacol. 37: 1271-1274, 1988.
Commins
S, Gigg J, Anderson M and O'Mara SM. Interaction
between paired-pulse facilitation and long-term potentiation in the projection
from hippocampal area CA1 to the subiculum.
Neuroreport 9:4109-4113, 1998.
Conti
A, Maestroni GJ. HPLC
validation of a circadian melatonin rhythm in the pineal gland of inbred mice.
J
Pineal Res. 20:138-144, 1996.
Conti,
A. and Maestroni, G. J. Melatonin rhythms in mice: role in autoimmune and
lymphoproliferative diseases. Ann.N.Y.Acad.Sci. 840: 395-410, 1998.
Conway
S, Drew JE, Canning SJ, Barrett P, Jockers R, Strosberg AD, Guardiola-Lemaitre
B, Delagrange P and Morgan PJ. Identification of Mel1a melatonin receptors in
the human embryonic kidney cell line HEK293: evidence of G protein-coupled
melatonin receptors which do not mediate the inhibition of stimulated cyclic AMP
levels. FEBS Lett. 407: 121-126, 1997.
Costa
EJ, Lopes RH and Lamy-Freund MT. Permeability of pure lipid bilayers to
melatonin. J.Pineal Res. 19: 123-126, 1995.
Costa
EJ, Shida CS, Biaggi MH, Ito AS and Lamy-Freund MT. How melatonin interacts with
lipid bilayers: a study by fluorescence and ESR spectroscopies. FEBS Lett. 416:
103-106, 1997.
Costa
ET, Soto EE, Cardoso RA, Olivera DS and Valenzuela CF.
Acute effects of ethanol on kainate receptors in cultured hippocampal
neurons. Alcohol Clin Exp Res. 2000;24(2):
220-5
Creager
R, Dunwiddie T and Lynch G. Paired-pulse
and frequency facilitation in the CA1 region
of the in vitro rat hippocampus. J
Physiol 299:409-424, 1980.
Danilenko
KV, Putilov AA, Russkikh GS, Duffy LK and Ebbesson SO. Diurnal and seasonal
variations of melatonin and serotonin in women with seasonal affective disorder.
Arctic Med.Res. 53: 137-145, 1994.
Deacon
SJ and Arendt J. Phase-shifts in melatonin, 6-sulphatoxymelatonin and alertness
rhythms after treatment with moderately bright light at night.
Clin.Endocrinol.(Oxf) 40: 413-420, 1994.
Deveson
S, Howarth JA, Arendt J and Forsyth IA. In vitro autoradiographical
localization of melatonin binding sites in the caprine brain. J.Pineal Res. 13:
6-12, 1992.
Dittman
JS, Kreitzer AC and Regehr WG. Interplay
between facilitation, depression, and residual calcium at three presynaptic
terminals. J Neurosci 20:1374-1385, 2000.
Dubocovich
ML. Melatonin is a potent modulator of dopamine release in the
retina. Nature 306: 782-784, 1983.
Dubocovich
ML. Melatonin receptors: are there multiple subtypes? Trends Pharmacol.Sci. 16:
50-56, 1995.
Dubocovich
ML, Masana MI, Iacob S and Sauri DM. Melatonin receptor antagonists that
differentiate between the human Mel1a and Mel1b recombinant subtypes are used to
assess the pharmacological profile of the rabbit retina ML1 presynaptic
heteroreceptor. Naunyn Schmiedebergs Arch.Pharmacol. 355: 365-375, 1997.
Dubocovich
ML and Takahashi JS. Use of 2-[125I]iodomelatonin to characterize melatonin
binding sites in chicken retina. Proc.Natl.Acad.Sci.U.S.A 84: 3916-3920, 1987.
Dubocovich
ML, Yun K, Al Ghoul WM, Benloucif S and Masana MI. Selective MT2 melatonin
receptor antagonists block melatonin-mediated phase advances of circadian
rhythms. FASEB J. 12: 1211-1220, 1998.
Duncan
MJ, Takahashi JS and Dubocovich ML. Characterization of 2-[125I]iodomelatonin
binding sites in hamster brain. Eur.J.Pharmacol. 132: 333-334, 1986.
Eison
AS and Mullins UL. Melatonin binding sites are functionally coupled to
phosphoinositide hydrolysis in Syrian hamster RPMI 1846 melanoma cells. Life
Sci. 53: L393-L398, 1993.
El-Sherif
Y, Hogan MV, Tesoriero J and Wieraszko A. Factors regulating the influence of
melatonin on hippocampal evoked potentials: comparative studies on different
strains of mice. Brain Res. 945: 191-201, 2002.
El-Sherif
Y, Singh N, Khan T and Wieraszko A. The effect of glutamate uptake inhibitors on
hippocampal evoked potentials in vitro. Acta Neurobiol.Exp.(Warsz.) 59:
89-97, 1999.
El-Sherif
Y, Wieraszko A, Banerjee P and Penington NJ. ATP modulates Na(+) channel gating
and induces a non-selective cation current in a neuronal hippocampal cell line.
Brain Res. 904: 307-317, 2001.
Escames
G, Acuna CD and Vives F. Melatonin-dopamine interaction in the striatal
projection area of sensorimotor cortex in the rat. Neuroreport 7: 597-600, 1996.
Faillace
MP, las Heras MA, Sarmiento MI and Rosenstein RE.
Daily variations in 2-[125I]melatonin specific binding in the golden
hamster retina. Neuroreport 7: 141-144, 1995.
Faillace
MP, Sarmiento MI and Rosenstein RE. Melatonin effect on [3H] glutamate uptake
and release in the golden hamster retina. J.Neurochem. 67: 623-628, 1996.
Farr
SA, Flood JF, Morley JE. The effect
of cholinergic, GABAergic, serotonergic, and glutamatergic receptor modulation
on posttrial memory processing in the hippocampus. Neurobiol. Learn. Mem.
73:150-167, 2000.
Fauteck
J, Schmidt H, Lerchl A, Kurlemann G and Wittkowski W. Melatonin in epilepsy:
first results of replacement therapy and first clinical results. Biol.Signals
Recept. 8: 105-110, 1999a.
Fauteck
JD, Dittgen M, Farker K, Hoffmann A, Hoffmann H, Lerchl A and Wittkowski W.
Melatonin and aging: relevance for clinical approach? J. Endocrinol. Invest.
22(10 Suppl):90-91, 1999b.
Flood
JF, Morley PM and Morley JE. Age-related
changes in learning, memory, and lipofucin as a function of the percentage of
SAMP8 genes. Physiol. Behav. 58:819-822, 1995.
Folkard
S, Arendt J and Clark M. Can melatonin improve shift workers' tolerance of the
night shift? Some preliminary findings. Chronobiol.Int. 10: 315-320, 1993.
Fujieda
H, Hamadanizadeh SA, Wankiewicz E, Pang SF and Brown GM. Expression of mt1
melatonin receptor in rat retina: evidence for multiple cell targets for
melatonin. Neuroscience 93: 793-799, 1999.
Fukawa
E, Tanaka H and Makino I. Identification and characterization of guanine
nucleotide-sensitive melatonin receptors in chicken brain. Neuropharmacology 34:
767-776, 1995.
Garcia-Patterson
A, Puig-Domingo M and Webb SM. Thirty years of human pineal research: do we know
its clinical relevance? J.Pineal Res. 20: 1-6, 1996.
Garcia-Perganeda
A, Guerrero JM, Rafii-El-Idrissi M, Paz Romero M, Pozo D and Calvo JR.
Characterization of membrane melatonin receptor in mouse peritoneal
macrophages: inhibition of adenylyl cyclase by a pertussis toxin-sensitive G
protein. J Neuroimmunol 95:85-94,
1999
Gauer
F, Masson-Pevet M, Saboureau M, George D and Pevet P. Differential seasonal
regulation of melatonin receptor density in the pars tuberalis and the
suprachiasmatic nuclei: a study in the hedgehog (Erinaceus europaeus, L.).
J.Neuroendocrinol. 5: 685-690, 1993.
Geinisman
Y. Structural synaptic modifications associated with hippocampal LTP and
behavioral learning. Cereb.Cortex 10: 952-962, 2000a.
Geinisman
Y, Disterhoft JF, Gundersen HJ, McEchron MD, Persina IS, Power JM, Van der Zee
EA and West MJ. Remodeling of hippocampal synapses after hippocampus-dependent
associative learning. J.Comp Neurol. 417: 49-59, 2000b.
Godson
C and Reppert SM. The Mel1a melatonin receptor is coupled to parallel signal
transduction pathways. Endocrinology 138: 397-404, 1997.
Gonzales
RG and Armstrong DL. Effects of melatonin on synaptic transmission and long-term
potentiation in the dentate gyrus of the hippocampus. Abstr Soc Neurosci 21:
615.11, 1995.
Gonzalez
R, Sanchez A, Ferguson JA, Balmer C, Daniel C, Cohn A and Robinson WA. Melatonin
therapy of advanced human malignant melanoma. Melanoma Res. 1: 237-243, 1991.
Gottschalk
W, Pozzo-Miller LD, Figurov A and Lu B. Presynaptic
modulation of synaptic transmission and plasticity by brain-derived neurotrophic
factor in the developing hippocampus. J
Neurosci. 18:6830-6839, 1998.
Grover
LM. Evidence for postsynaptic induction and expression of NMDA receptor
independent LTP. J.Neurophysiol. 79: 1167-1182, 1998.
Guardiola-Lemaitre
B. Toxicology of melatonin. J.Biol.Rhythms 12: 697-706, 1997.
Gutierrez
R, Leff P, Romo-Parra H, Acevedo R and Anton B.
Orpanin-fq/nociception inhibits kindling epileptogenesis and enhances
hippocampal feed-forward inhibition. Neuroscience 105:325-333, 2000.
Harris
KM and Teyler TJ. Age differences in a circadian influence on hippocampal LTP.
Brain Res. 262:69-73, 1983.
Hayashi
Y, Shi SH, Esteban JA, Piccini A, Poncer JC and Malinow R. Driving AMPA
receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain
interaction. Science 287: 2262-2267, 2000.
Hazlerigg
DG, Gonzalez-Brito A, Lawson W, Hastings MH and Morgan PJ.
Prolonged
exposure to melatonin leads to time-dependent sensitization of adenylate cyclase
and down-regulates melatonin receptors in pars tuberalis cells from ovine
pituitary. Endocrinology
132:285-292, 1993.
Hirata
F, Hayaishi O, Tokuyama T and Seno S. In vitro and in vivo
formation of two new metabolites of melatonin. J.Biol.Chem. 249: 1311-1313,
1974.
Hodde
KC. The vascularization of the rat pineal organ. Prog.Brain Res. 52: 39-44,
1979a.
Hodde
KC and Veltman WA. The vascularization of the pineal gland (epiphysis cerebri)
of the rat. Scan Electron Microsc. 3: 369-374, 1979b.
Hogan
MV, El Sherif Y and Wieraszko A. The modulation of neuronal activity by
melatonin: in vitro studies on mouse hippocampal slices. J.Pineal Res.
30: 87-96, 2001.
Huan
C, Zhou M, Wu M, Zhang Z and Mei Y. Activation of melatonin receptor increases a
delayed rectifier K+ current in rat cerebellar granule cells. Brain Res. 917:
182-190, 2001.
Huerto-Delgadillo
L, Anton-Tay F and Benitez-King G. Effects of melatonin on microtubule assembly
depend on hormone concentration: role of melatonin as a calmodulin antagonist.
J.Pineal Res. 17: 55-62, 1994.
Huie
JM, Sharma RP, Coulombe RA Jr. Diurnal
alterations of catecholamines, indoleamines and their metabolites in specific
brain regions of the mouse. Comp. Biochem. Physiol. C Pharmacol. Toxicol.
Endocrinol. 94:575-579, 1989.
Hunt
AE, Al Ghoul WM, Gillette MU and Dubocovich ML. Activation of MT(2) melatonin
receptors in rat suprachiasmatic nucleus phase advances the circadian clock.
Am.J.Physiol Cell Physiol 280: C110-C118, 2001.
Iigo
M, Furukawa K, Hattori A, Ohtani-Kaneko R, Hara M, Suzuki T, Tabata M and Aida
K. Ocular melatonin rhythms in the goldfish, Carassius auratus. J.Biol.Rhythms
12: 182-192, 1997a.
Iigo
M, Hara M, Ohtani-Kaneko R, Hirata K, Tabata M and Aida K. Photic and circadian
regulations of melatonin rhythms in fishes. Biol.Signals 6: 225-232, 1997b.
Imendra
KG, Fujiyama R, Miyamoto T, Okada Y and Sato T.
Serotonin
inhibits voltage-gated sodium current by cyclic adenosine
monophosphate-dependent mechanism in bullfrog taste receptor cells.
Neurosci Lett. 294:151-154, 2000.
Impey
S, Mark M, Villacres EC, Poser S, Chavkin C and Storm DR. Induction of
CRE-mediated gene expression by stimuli that generate long- lasting LTP in area
CA1 of the hippocampus. Neuron 16: 973-982, 1996.
Ireland
DR and Abraham WC. Group I mGluRs
increase excitability of hippocampal CA1 pyramidal neurons by a PLC-independent
mechanism. J Neurophysiol.
88:107-116, 2002.
.
Jackson
GL, Jansen H and Kao C. Continuous exposure of Suffolk ewes to an equatorial
photoperiod disrupts expression of the annual breeding season. Biol.Reprod. 42:
63-73, 1990.
Jiang
ZG, Nelson CS and Allen CN. Melatonin activates an outward current and inhibits
Ih in rat suprachiasmatic nucleus neurons. Brain Res. 687: 125-132, 1995.
Johnston
D and Amaral DG. Chapter 11 – Hippocampus; “The Synaptic Organization of the
Brain” 4th ed. Edited by Gordon Shepherd, Oxford Press, 1998.
Jontes
JD and Smith SJ. Filopodia,
spines, and the generation of synaptic diversity.
Neuron
27:11-14, 2000.
Jun
K, Choi G, Yang SG, Choi KY, Kim H, Chan GC, Storm DR, Albert C, Mayr GW, Lee CJ
and Shin HS. Enhanced hippocampal CA1 LTP but normal spatial learning in
inositol 1,4,5-trisphosphate 3-kinase(A)-deficient mice. Learn.Mem. 5: 317-330,
1998.
Kafka
MS, Benedito MA, Roth RH, Steele LK, Wolfe WW and Catravas GN. Circadian rhythms
in catecholamine metabolites and cyclic nucleotide production. Chronobiol.Int.
101-115, 1986.
Kallal
L and Benovic JL. Using green fluorescent proteins to study G-protein-coupled
receptor localization and trafficking. Trends Pharmacol.Sci. 21: 175-180, 2000.
Kane
MA, Johnson A, Nash AE, Boose D, Mathai G, Balmer C, Yohn JJ and Robinson WA.
Serum melatonin levels in melanoma patients after repeated oral administration.
Melanoma Res. 4: 59-65, 1994.
Kapur,
A., Lytton, W. W., Ketchum, K. L., and Haberly, L. B. Regulation of the NMDA
component of EPSPs by different components of postsynaptic GABAergic inhibition:
computer simulation analysis in piriform cortex. J.Neurophysiol. 78: 2546-2559,
1997.
Kapur,
J., Stringer, J. L., and Lothman, E. W. Evidence that repetitive seizures in the
hippocampus cause a lasting reduction of GABAergic inhibition. J.Neurophysiol.
4: 417-426, 1989.
Karnup
S, Stelzer A. Temporal
overlap of excitatory and inhibitory afferent input in guinea-pig CA1 pyramidal
cells. J
Physiol 516:485-504, 1999.
Kennaway
DJ, Hugel HM and Rowe SA. Characterization
of the chicken brain melatonin-binding protein using iodinated and tritiated
ligands. J. Pineal Res. 17: 137-148, 1994.
Kennaway
DJ, Lushington K, Dawson D, Lack L, van den HC and Rogers N. Urinary
6-sulfatoxymelatonin excretion and aging: new results and a critical review of
the literature. J.Pineal Res. 27: 210-220, 1999.
Kirov
SA and Harris KM. Dendrites are more spiny on mature hippocampal neurons when
synapses are inactivated. Nat.Neurosci. 2: 878-883, 1999.
Kirov
SA, Sorra KE and Harris KM. Slices have more synapses than perfusion-fixed
hippocampus from both young and mature rats. J.Neurosci. 19: 2876-2886, 1999.
Konecna
I, Holecek V, Racek J, Trefil L and Rokyta R. Antioxidant effects of melatonin.
Cas.Lek.Cesk. 140: 262-266, 2001.
Krasovich
M and Benson B. Effects of reserpine and p-chlorophenylalanine on the circadian
rhythm of granulated vesicles in the pinealocytes of mice. Cell Tissue Res. 203:
457-467, 1979.
Kullmann
DM, Erdemli G, Asztely F. LTP
of AMPA and NMDA receptor-mediated signals: evidence for presynaptic expression
and extrasynaptic glutamate spill-over. Neuron
17:461-474, 1996.
Kullmann
DM, Perkel DJ, Manabe T and Nicoll RA. Ca2+ entry via postsynaptic
voltage-sensitive Ca2+ channels can transiently potentiate excitatory synaptic
transmission in the hippocampus. Neuron 9: 1175-1183, 1992.
Kumar
V, Gwinner E and Van't Hof TJ. Circadian rhythms of melatonin in European
starlings exposed to different lighting conditions: relationship with locomotor
and feeding rhythms. J.Comp Physiol [A] 186: 205-215, 2000.
Kvetnoy
I, Sandvik AK and Waldum HL. The diffuse neuroendocrine system and extrapineal
melatonin. J.Mol.Endocrinol. 18: 1-3, 1997.
Laudon
M, Nir I and Zisapel N. Melatonin receptors in discrete brain areas of the male
rat. Impact of aging on density and on circadian rhythmicity. Neuroendocrinology
48: 577-583, 1988.
Lee
MC, Chung YT, Lee JH, Jung JJ, Kim HS and Kim SU. Antioxidant effect of
melatonin in human retinal neuron cultures. Exp.Neurol. 172: 407-415, 2001.
Leon
J, Macias M, Escames G, Camacho E, Khaldy H, Martin M, Espinosa A, Gallo MA and
Acuna-Castroviejo D. Structure-related inhibition of calmodulin-dependent
neuronal nitric- oxide synthase activity by melatonin and synthetic kynurenines.
Mol.Pharmacol. 58: 967-975, 2000.
Leon
J, Vives F, Crespo E, Camacho E, Espinosa A, Gallo MA, Escames G and
Acuna-Castroviejo D. Modification of nitric oxide synthase activity and neuronal
response in rat striatum by melatonin and kynurenine derivatives.
J.Neuroendocrinol. 10: 297-302, 1998a.
Leon
J, Vives F, Gomez I, Camacho E, Gallo MA, Espinosa A, Escames G and
Acuna-Castroviejo D. Modulation of rat striatal glutamatergic response in search
for new neuroprotective agents: evaluation of melatonin and some kynurenine
derivatives. Brain Res.Bull. 45: 525-530, 1998b.
Li
GL, Li P and Yang XL. Melatonin modulates gamma-aminobutyric acid(A)
receptor-mediated currents on isolated carp retinal neurons. Neurosci.Lett. 301:
49-53, 2001.
Li
P-K, Witt-Enderby PA, Chu GH, Gillen ML and Parekh T.
The Development of a Charged Melatonin Receptor Ligand.
Bioorganic and Medicinal Chemistry Letters 7:2409-2414, 1997.
Lie
AA, Becker A, Behle K, Beck H, Malitschek B, Conn PJ, Kuhn R, Nitsch R, Plaschke
M, Schramm J, Elger CE, Wiestler OD and Blumcke I. Up-regulation of the
metabotropic glutamate receptor mGluR4 in hippocampal neurons with reduced
seizure vulnerability. Ann.Neurol. 47: 26-35, 2000.
Lincoln
GA, Almeida OF and Arendt J. Role of melatonin and circadian rhythms in seasonal
reproduction in rams. J.Reprod.Fertil.Suppl 30: 23-31, 1981.
Lissin
DV, Carroll RC, Nicoll RA, Malenka RC and von Zastrow M. Rapid,
activation-induced redistribution of ionotropic glutamate receptors in cultured
hippocampal neurons. J.Neurosci. 19: 1263-1272, 1999.
Lissoni
P, Barni S, Crispino S, Tancini G and Fraschini F. Endocrine and immune effects
of melatonin therapy in metastatic cancer patients. Eur.J.Cancer Clin.Oncol. 25:
789-795, 1989.
Lissoni
P, Barni S, Tancini G, Crispino S, Paolorossi F, Lucini V, Mariani M, Cattaneo
G, Esposti D and Esposti G. Clinical
study of melatonin in untreatable advanced cancer patients. Tumori 73: 475-480,
1987.
Liu
DK, Horner RL and Wojtowicz JM. Time of day determines modulation of synaptic
transmission by adenosine in the rat hippocampal slices. Neurosci.Lett. 282:
200-202, 2000.
Luscher
C and Frerking M. Restless AMPA receptors: implications for synaptic
transmission and plasticity. TINS 24:665-670, 2001.
Luscher
C, Nicoll RA, Malenka RC and Muller D. Synaptic plasticity and dynamic
modulation of the postsynaptic membrane. Nat.Neurosci. 3: 545-550, 2000.
Maren
S and Baundry M. Properties and mechanisms of synaptic plasticity in the
mammalian brain: relationship to learning and memory. Learning and Memory
63:1-18, 1995.
Marshall
KA, Reiter RJ, Poeggeler B, Aruoma OI and Halliwell B. Evaluation of the
antioxidant activity of melatonin in vitro. Free Radic.Biol.Med. 21:
307-315, 1996.
Mazzucchelli
C, Pannacci M, Nonno R, Lucini V, Fraschini F and Stankov BM. The melatonin
receptor in the human brain: cloning experiments and distribution studies. Brain
Res.Mol.Brain Res. 39: 117-126, 1996.
McLellan
TM, Gannon GA, Zamecnik J, Gil V and Brown GM. Low doses of melatonin and
diurnal effects on thermoregulation and tolerance to uncompensable heat stress.
J.Appl.Physiol 87: 308-316, 1999.
McMillan
TM, Powell GE, Janota I and Polkey CE. Relationships between neuropathology and
cognitive functioning in temporal lobectomy patients.
J.Neurol.Neurosurg.Psychiatry 50: 167-176, 1987.
Meiri
N, Sun MK, Segal Z and Alkon DL. Memory and long-term potentiation (LTP)
dissociated: normal spatial memory despite CA1 LTP elimination with Kv1.4
antisense. Proc.Natl.Acad.Sci.U.S.A. 95: 15037-15042, 1998.
Minneman
KP, Lynch H and Wurtman RJ. Relationship between environmental light intensity
and retina-mediated suppression of rat pineal serotonin-N-acetyl-transferase.
Life Sci. 15: 1791-1796, 1974.
Molina-Carballo
A, Munoz-Hoyos A, Reiter RJ, Sanchez-Forte M, Moreno-Madrid F, Rufo-Campos M,
Molina-Font JA and Acuna-Castroviejo D. Utility of high doses of melatonin as
adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two
years' experience. J.Pineal Res. 23: 97-105, 1997.
Moller
M and Baeres FM. The anatomy and
innervation of the mammalian pineal gland.
Cell Tissue Res. 309:139-150, 2002.
Moretti
RM, Marelli MM, Maggi R, Dondi D, Motta M and Limonta P. Antiproliferative
action of melatonin on human prostate cancer LNCaP cells. Oncol.Rep. 7: 347-351,
2000.
Morgan
PJ, Barrett P, Howell HE and Helliwell R. Melatonin receptors: localization,
molecular pharmacology and physiological significance. Neurochem.Int. 24:
101-146, 1994.
Mullins
UL and Eison AS. Pharmacologic characterization of melatonin-mediated
phosphoinositide hydrolysis in pigeon brain. J.Pineal Res. 17: 33-38, 1994.
Mumby
DG, Astur RS, Weisend MP and Sutherland RJ. Retrograde amnesia and selective
damage to the hippocampal formation: memory for places and object
discriminations. Behav.Brain Res. 97-107, 1999.
Murakami
N, Nakamura H, Nishi R, Marumoto N and Nasu T. Comparison of circadian
oscillation of melatonin release in pineal cells of house sparrow, pigeon and
Japanese quail, using cell perfusion systems. Brain Res. 651: 209-214, 1994.
Musshoff
U, Riewenherm D, Berger E, Fauteck JD and Speckmann EJ.
Melatonin
receptors in rat hippocampus: molecular and functional investigations.
Hippocampus
12:165-173, 2002.
Neusch
C, Bohme V, Riesland N, Althaus M and Moser A.
The dopamine D2 receptor agonist alpha-dihydroergocryptine modulates
voltage-gated sodium channels in the rat caudate-putamen.
J Neural Transm.107:531-541, 2000.
Niles
LP. [3H] melatonin binding in membrane and cytosol fractions from rat and calf
brain. J.Pineal Res. 4: 89-98, 1987.
Niles
LP and Hashemi F. Picomolar-affinity binding and inhibition of adenylate cyclase
activity by melatonin in Syrian hamster hypothalamus. Cell Mol.Neurobiol. 10:
553-558, 1990.
Niles
LP and Peace CH. Allosteric modulation of t-[35S]butylbicyclophosphorothionate
binding in rat brain by melatonin. Brain Res.Bull. 24: 635-638, 1990.
Niles
LP, Wong YW, Mishra RK and Brown GM. Melatonin receptors in brain.
Eur.J.Pharmacol. 55: 219-220, 1979.
Niles
LP, Ye M, Pickering DS and Ying SW. Pertussis toxin blocks melatonin-induced
inhibition of forskolin- stimulated adenylate cyclase activity in the chick
brain. Biochem.Biophys.Res.Commun. 178: 786-792, 1991.
Nonno
R, Lucini V, Stankov B and Fraschini F. 2-[125I]iodomelatonin binding sites in
the bovine hippocampus are not sensitive to guanine nucleotides. Neurosci.Lett.
194: 113-116, 1995.
Nonno
R, Pannacci M, Lucini V, Angeloni D, Fraschini F and Stankov BM. Ligand efficacy
and potency at recombinant human MT2 melatonin receptors: evidence for agonist
activity of some mt1-antagonists. Br.J.Pharmacol. 127: 1288-1294, 1999.
Nosjean
O, Ferro M, Coge F, Beauverger P, Henlin JM, Lefoulon F, Fauchere JL, Delagrange
P, Canet E and Boutin JA. Identification of the melatonin-binding site MT3 as
the quinone reductase 2. J.Biol.Chem. 275: 31311-31317, 2000.
Nowak
JZ, Zawilska JB and Trzepizur K. Alpha
2-adrenergic receptors regulate generation of cyclic AMP in the pineal gland,
but not in cerebral cortex of chick. Pol
J Pharmacol. 49:137-141, 1997
Oblap
R and Olszanska B. Expression of melatonin receptor transcripts (mel-1a, mel-1b
and mel- 1c) in Japanese quail oocytes and eggs. Zygote. 9: 237-244, 2001.
Olney JW, Collins RC and Sloviter RS. Excitotoxic mechanisms of epileptic brain
damage. Adv.Neurol. 44: 857-877, 1986.
Oren
DA, Turner EH and Wehr TA. Abnormal circadian rhythms of plasma melatonin and
body temperature in the delayed sleep phase syndrome.
J.Neurol.Neurosurg.Psychiatry 58: 379, 1995.
Ortiz
GG, Sanchez-Ruiz Y, Tan DX, Reiter RJ, Benitez-King G and Beas-Zarate C.
Melatonin, vitamin E, and estrogen reduce damage induced by kainic acid in the
hippocampus: potassium-stimulated GABA release. J.Pineal Res. 31: 62-67, 2001.
Pang
SF and Brown GM. Regional concentrations of melatonin in the rat brain in the
light and dark period. Life Sci. 33: 1199-1204, 1983.
Pang
SF, Tsang CW, Hong GX, Yip PC, Tang PL and Brown GM. Fluctuation of blood
melatonin concentrations with age: result of changes in pineal melatonin
secretion, body growth, and aging. J.Pineal Res. 8: 179-192, 1990.
Pang
SF, Ayre EA, Poon AM, Pang CS, Yuan H, Wang ZP, Song Y and Brown GM.
Effects of guanosine 5’-O-(3-thiotriphosphate) on 2[125I]-iodomelatonin
binding in the chicken lung, brain and kidney: hypothesis of different subtypes
of high affinity melatonin receptors. Biol
Signals 2: 27-36, 1993.
Paul
P, Lahaye C, Delagrange P, Nicolas JP, Canet E and Boutin JA.
Characterization
of 2-[125I]iodomelatonin binding sites in Syrian hamster peripheral organs. J
Pharmacol. Exp. Ther. 290:334-340; 1999.
Peoples
RW and Weight FF. Differential
alcohol modulation of GABA(A) and NMDA receptors.
Neuroreport
10:97-101, 1999.
Pickard
L, Noel J, Duckworth JK, Fitzjohn SM, Henley JM, Collingridge GL and Molnar E.
Transient
synaptic activation of NMDA receptors leads to the insertion of native AMPA
receptors at hippocampal neuronal plasma membranes.
Neuropharmacology
41:700-713, 2001.
Pierpaoli
W,
Davies
O, Colman
C and Regelson
W. Melatonin
Miracle: Nature's Sex-Enhancing, Disease-Fighting, Age-Reversing Hormone.
Simon
& Schuster, 1993.
Pierrefiche
G, Topall G, Courboin G, Henriet I and Laborit H. Antioxidant activity of
melatonin in mice. Res.Commun.Chem.Pathol.Pharmacol. 80: 211-223, 1993.
Pickering
DS and Niles LP. 2[125I]-iodomelatonin
binding sites in hamster and chick exhibit differential sensitivity to prazosin.
J Phar Pharmacol. 41: 356-357, 1989.
Poelchen
W, Proctor WR and Dunwiddie TV. The
in vitro ethanol sensitivity of hippocampal synaptic gamma-aminobutyric
acid(A) responses differs in lines of mice and rats genetically selected for
behavioral sensitivity or insensitivity to ethanol.
J
Pharmacol Exp Ther. 295:741-746, 2000.
Raghavan
AV, Horowitz JM and Fuller CA. Diurnal modulation of long-term potentiation in
the hamster hippocampal slice. Brain Res. 833: 311-314, 1999.
Raynaud
F, Mauviard F, Geoffriau M, Claustrat B and Pevet P. Plasma 6-hydroxymelatonin,
6-sulfatoxymelatonin and melatonin kinetics after melatonin administration to
rats. Biol.Signals 2: 358-366, 1993.
Recasens
M. Putative molecular mechanisms underlying long term potentiation (LTP): the
key role of excitatory amino acid receptors. Therapie 50: 19-34, 1995.
Reilly
CE. Hippocampus selectively supports episodic memory retrieval. J.Neurol. 248:
1014-1015, 2001.
Reiter
RJ. The mammalian pineal gland: structure and function. Am.J.Anat. 162: 287-313,
1981.
Reiter
RJ. Normal patterns of melatonin levels in the pineal gland and body fluids of
humans and experimental animals. J.Neural Transm.Suppl 21: 35-54, 1986.
Reiter
RJ. Neuroendocrine effects of light. Int.J.Biometeorol. 35: 169-175, 1991.
Reiter
RJ. Interactions of the pineal hormone melatonin with oxygen-centered free
radicals: a brief review. Braz.J.Med.Biol.Res. 26: 1141-1155, 1993.
Reiter
RJ. Pineal function during aging: attenuation of the melatonin rhythm and its
neurobiological consequences. Acta Neurobiol.Exp.(Warsz.) 54 Suppl: 31-39, 1994.
Reiter
RJ. Functional diversity of the pineal hormone melatonin: its role as an
antioxidant. Exp.Clin.Endocrinol.Diabetes 104: 10-16, 1996.
Reiter
RJ. Oxidative damage in the central nervous system: protection by melatonin.
Prog.Neurobiol. 56: 359-384, 1998.
Reiter
RJ, Tan D, Kim SJ, Manchester LC, Qi W, Garcia JJ, Cabrera JC, El Sokkary G and
Rouvier-Garay V. Augmentation of indices of oxidative damage in life-long
melatonin- deficient rats. Mech.Ageing Dev. 110: 157-173, 1999.
Reiter
RJ and Tan DX. Role
of CSF in the transport of melatonin. J
Pineal Res. 33:61, 2002.
Reiter
RJ and Tan DX. What constitutes a
physiological concentration of melatonin? J
Pineal Res. 34: 79-80, 2003.
Reppert
SM. Melatonin receptors: molecular biology of a new family of G protein- coupled
receptors. J.Biol.Rhythms 12: 528-531, 1997.
Reppert
SM, Perlow MJ, Tamarkin L and Klein DC. A diurnal melatonin rhythm in primate
cerebrospinal fluid. Endocrinology 104: 295-301, 1979.
Reppert
SM, Weaver DR and Ebisawa T. Cloning and characterization of a mammalian
melatonin receptor that mediates reproductive and circadian responses. Neuron
13: 1177-1185, 1994.
Reppert
SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA and Gusella JF.
Molecular characterization of a second melatonin receptor expressed in
human retina and brain: the Mel1b melatonin receptor. Proc
Natl Acad Sci 92:8734-8738, 1995.
Rich
A, Farrugia G and Rae JL. Effects of melatonin on ionic currents in cultured
ocular tissues. Am.J.Physiol 276: C923-C929, 1999.
Roberts
E. Some thoughts about GABA and the basal ganglia. Res Publ Assoc Res Nerv Ment
Dis. 55: 191-203, 1976.
Rock
DM and Taylor CP. Effects of diazepam, pentobarbital, phenytoin and
pentylenetetrazol on hippocampal paired-pulse inhibition in vivo.
Neurosci.Lett. 65: 265-270, 1986.
Rollag
MD, Morgan RJ and Niswender GD. Utilization of the convolution integral to
calculate rates of melatonin secretion into blood and CSF of sheep. ISA Trans.
16: 91-96, 1977.
Romero
MP, Garcia-Perganeda A, Guerrero JM and Osuna C. Membrane-bound calmodulin in
Xenopus laevis oocytes as a novel binding site for melatonin. FASEB J. 12:
1401-1408, 1998.
Ross
AW, Webster CA, Thompson M, Barrett P and Morgan PJ. A novel interaction between
inhibitory melatonin receptors and protein kinase C-dependent signal
transduction in ovine pars tuberalis cells. Endocrinology 139: 1723-1730, 1998.
Rothman
SM and Olney JW. Glutamate and the pathophysiology of hypoxic--ischemic brain
damage. Ann.Neurol. 19: 105-111, 1986.
Rousseau
A, Petren S, Plannthin J, Eklundh T and Nordin C. Serum and cerebrospinal fluid
concentrations of melatonin: a pilot study in healthy male volunteers. J.Neural
Transm. 106: 883-888, 1999.
Saarelainen
T, Pussinen R, Koponen E, Alhonen L, Wong G, Sirvio J and Castren E.
Transgenic
mice overexpressing truncated trkB neurotrophin receptors in neurons have
impaired long-term spatial memory but normal hippocampal LTP.
Synapse
38:102-104, 2000.
Sakimura
K, Kutsuwada T, Ito I, Manabe T, Takayama C, Kushiya E, Yagi T, Aizawa S, Inoue
Y and Sugiyama H. Reduced hippocampal LTP and spatial learning in mice lacking
NMDA receptor epsilon 1 subunit. Nature 1995.Jan.12.373. 151-155, 1995.
Sandyk
R. Pineal melatonin functions and
the depression of Parkinson's disease: a hypothesis. Int.J.Neurosci. 51: 73-77,
1990.
Sandyk
R and Kay SR. Melatonin secretion and the pathophysiology of Meige's disease
(idiopathic orofacial dystonia): a hypothesis. Funct.Neurol. 5: 165-170, 1990.
Savaskan
E, Olivieri G, Brydon L, Jockers R, Krauchi K, Wirz-Justice A and Muller-Spahn
F. Cerebrovascular melatonin MT1-receptor alterations in patients with
Alzheimer's disease. Neurosci.Lett. 308: 9-12, 2001.
Sayin
U, Rutecki PA, Mellanby J and Sutula TP. Gamma-vinyl
GABA reduces paired pulse inhibition in the rat dentate gyrus in vivo and
in vitro. Epilepy Research 44:109-117, 2001.
Schulz
PE, Cook EP and Johnston D. Using
paired-pulse facilitation to probe the mechanism for long-term potentiation
(LTP). J Physiol (Paris) 89:3-9,
1995.
Schuster
C, Gauer F, Malan A, Recio J, Pevet P and Masson-Pevet M. The circadian clock,
light/dark cycle and melatonin are differentially involved in the expression of
daily and photoperiodic variations in mt(1) melatonin receptors in the Siberian
and Syrian hamsters. Neuroendocrinology 74: 55-68, 2001.
Scoville
WB and Milner B. Loss of recent memory after bilateral hyppocampal lesions.
Journal of Neurol. Neurosurg and Psychiat 20: 11-21, 1957.
Segal
M. The action of serotonin in the rat hippocampal slice preparation. J.Physiol
303: 423-439, 1980.
Semyanov
A and Kullmann DM. Kainate
receptor-dependent axonal depolarization and action potential initiation in
interneurons. Nat
Neurosci. 4:718-723, 2001.
Semm
P, Demaine C and Vollrath L. Electrical responses of pineal cells to melatonin
and putative transmitters. Evidence for circadian changes in sensitivity.
Exp.Brain Res. 43: 361-370, 1981.
Sharma
M, Palacios-Bois J, Schwartz G, Iskandar H, Thakur M, Quirion R and Nair NP.
Circadian rhythms of melatonin and cortisol in aging. Biol.Psychiatry 25:
305-319, 1989.
Shida
CS, Castrucci AM and Lamy-Freund MT. High melatonin solubility in aqueous
medium. J.Pineal Res. 16: 198-201, 1994.
Simson
PE, Criswell HE and Breese GR. Inhibition
of NMDA-evoked electrophysiological activity by ethanol in selected brain
regions: evidence for ethanol-sensitive and ethanol-insensitive NMDA-evoked
responses. Brain Res. 607: 9-16,
1993.
Sinclair
JG and Lo GF. Ethanol
blocks tetanic and calcium-induced long-term potentiation in the hippocampal
slice. Gen
Pharmacol. 17:231-233, 1986.
Siuciak
JA, Krause DN and Dubocovich ML. Quantitative pharmacological analysis of
2-125I-iodomelatonin binding sites in discrete areas of the chicken brain.
J.Neurosci. 11: 2855-2864, 1991.
Skaper
SD, Ancona B, Facci L, Franceschini D and Giusti P. Melatonin prevents the
delayed death of hippocampal neurons induced by enhanced excitatory
neurotransmission and the nitridergic pathway. FASEB J. 12: 725-731, 1998.
Skinner
DC and Malpaux B. High melatonin concentrations in third ventricular
cerebrospinal fluid are not due to Galen vein blood recirculating through the
choroid plexus. Endocrinology 140: 4399-4405, 1999.
Slanar
O, Pelisek V, Vanecek J. Melatonin inhibits pituitary adenylyl cyclase
activating polypetide- induced
increase of cyclic AMP accumulation and [Ca2+ ]i in
cultured cells of neonatal rat
pituitary. Neurochem Int 36: 213-219, 2000.
Somova
EV, Kolodub FA and Bondarenko LA. Chronobiological aspects of melatonin-produced
antioxidant effects in senescent rats. Bull.Exp.Biol.Med. 132: 887-889, 2001.
Southgate
GS, Daya S and Potgieter B. Melatonin plays a protective role in quinolinic
acid-induced neurotoxicity in the rat hippocampus. J.Chem.Neuroanat. 14:
151-156, 1998.
Stankov
B, Capsoni S, Lucini V, Fauteck J, Gatti S, Gridelli B, Biella G, Cozzi B and
Fraschini F. Autoradiographic localization of putative melatonin receptors in
the brains of two Old World primates: Cercopithecus aethiops and Papio ursinus.
Neuroscience 52: 459-468, 1993.
Stankov
B, Cozzi B, Lucini V, Capsoni S, Fauteck J, Fumagalli P and Fraschini F.
Localization and characterization of melatonin binding sites in the brain of the
rabbit (Oryctolagus cuniculus) by autoradiography and in vitro
ligand-receptor binding. Neurosci.Lett. 133: 68-72, 1991.
Stehle
J, Vanecek J and Vollrath L. Effects of melatonin on spontaneous electrical
activity of neurons in rat suprachiasmatic nuclei: an in vitro
iontophoretic study. J.Neural Transm. 78: 173-177, 1989.
Sugden
D, Pickering H, The MT and Garratt PJ. Melatonin
receptor pharmacology: toward subtype specificity.
Biol Cell 89:531-537, 1997.
Sun
W, Salvi RJ. Dopamine
modulates sodium currents in cochlear spiral ganglion neurons. Neuroreport.
12:803-807, 2001.
Suzuki
T. Messengers from the synapses to the nucleus (MSNs) that establish late phase
of long-term potentiation (LTP) and long-term memory. Neurosci.Res. 25: 1-6,
1996.
Tan
DX, Manchester LC, Burkhardt S, Sainz RM, Mayo JC, Kohen R, Shohami E, Huo YS,
Hardeland R and Reiter RJ. N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic
amine and melatonin metabolite, functions as a potent antioxidant. FASEB J. 15:
2294-2296, 2001.
Tan
DX, Poeggeler B, Reiter RJ, Chen LD, Chen S, Manchester LC and Barlow-Walden LR.
The pineal hormone melatonin inhibits DNA-adduct formation induced by the
chemical carcinogen safrole in vivo. Cancer Lett. 70: 65-71, 1993.
Thrun
LA, Moenter SM, O'Callaghan D, Woodfill CJ and Karsch FJ. Circannual alterations
in the circadian rhythm of melatonin secretion. J.Biol.Rhythms 10: 42-54, 1995.
Tomatis
ME, Orias R. Changes
in melatonin concentration in pineal gland in rats exposed to continuous light
or darkness. Acta
Physiol Lat Am 17:227-233, 1967.
Tosini
G, Bertolucci C and Foa A. The circadian system of reptiles: a multioscillatory
and multiphotoreceptive system. Physiol Behav. 72: 461-471, 2001.
Touitou
Y, Fevre M, Lagoguey M, Carayon A, Bogdan A, Reinberg A, Beck H, Cesselin F and
Touitou C. Age- and mental health-related circadian rhythms of plasma levels of
melatonin, prolactin, luteinizing hormone and follicle-stimulating hormone in
man. J.Endocrinol. 91: 467-475, 1981.
Tricoire
H, Locatelli A, Chemineau P and Malpaux B. Melatonin enters the cerebrospinal
fluid through the pineal recess. Endocrinology 143: 84-90, 2002.
Tsao
P and von Zastrow M. Downregulation of G protein-coupled receptors.
Curr.Opin.Neurobiol. 10: 365-369, 2000.
Tsien
JZ, Huerta PT, Tonegawa S. The
essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in
spatial memory. Cell
87:1327-1338, 1996.
Turek
FW, Zee P, Van Reeth O. Melatonin and aging.
Adv. Exp. Med. Biol. 460:435-440, 1999.
Ubeda
A, Trillo MA, House DE and Blackman CF. Melatonin enhances junctional transfer
in normal C3H/10T1/2 cells. Cancer Lett. 91: 241-245, 1995.
Upson
H and Benson H. Effects of blinding
on the ultrastructure of mouse pinealocytes with particular emphasis on the
dense core vesicles. Cell Tissue Res. 183:491-498, 1977.
Vacas
MI, Keller-Sarmiento MI and Cardinali DP. Pineal methoxyindoles depress calcium
uptake by rat brain synaptosomes. Brain Res. 294: 166-168, 1984.
Vakkuri
O, Leppaluoto J and Vuolteenaho O. Development and validation of a melatonin
radioimmunoassay using radioiodinated melatonin as tracer. Acta
Endocrinol.(Copenh) 106: 152-157, 1984.
Vanecek
J. Cellular mechanisms of melatonin action. Physiol Rev. 78: 687-721, 1998.
Vanecek
J and Watanabe K. Melatonin inhibits the increase of cyclic AMP in rat
suprachiasmatic neurons induced by vasoactive intestinal peptide. Neurosci.Lett.
252: 21-24, 1998.
Varga
Z, Panyi G, Peter M Jr., Pieri C, Csecsei G, Damjanovich S and Gaspar R Jr.
Multiple binding sites for melatonin on Kv1.3. Biophys.J. 80: 1280-1297, 2001.
Velazquez
JL and Carlen PL. Synchronization of GABAergic interneuronal networks during
seizure-like activity in the rat horizontal hippocampal slice. Eur.J.Neurosci.
11: 4110-4118, 1999.
Veylon
R. [The third eye. Confirmation of the role of the epiphysis as a regulator of
sexual activity in birds]. Nouv.Presse Med. 9: 2045, 1980.
Vivien-Roels
B, Arendt J and Bradtke J. Circadian and circannual fluctuations of pineal
indoleamines (serotonin and melatonin) in Testudo hermanni Gmelin (Reptilia,
Chelonia). I. Under natural conditions of photoperiod and temperature. Gen.Comp
Endocrinol. 37: 197-210, 1979.
Waldhauser
F and Dietzel M. Daily and annual rhythms in human melatonin secretion: role in
puberty control. Ann.N.Y.Acad.Sci. 453: 205-214, 1985.
Waldhauser
F, Ehrhart B and Forster E. Clinical aspects of the melatonin action: impact of
development, aging, and puberty, involvement of melatonin in psychiatric disease
and importance of neuroimmunoendocrine interactions. Experientia 49: 671-681,
1993.
Wall
PM and Messier C. Concurrent modulation of anxiety and memory. Behav. Brain Res.
109:229-241, 2000a.
Wall
PM and Messier C. U-69,593
microinjection in the infralimbic cortex reduces anxiety and enhances
spontaneous alteration memory in mice. Brain Res. 856:259-280, 2000b.
Wan
FJ, Berton F, Madamba SG, Francesconi W, Siggins GR.
Low
ethanol concentrations enhance GABAergic inhibitory postsynaptic potentials in
hippocampal pyramidal neurons only after block of GABAB receptors.
Proc
Natl Acad Sci USA 93:5049-5054, 1996.
Wan
Q, Man HY, Liu F, Braunton J, Niznik HB, Pang SF, Brown GM and Wang YT.
Differential modulation of GABAA receptor function by Mel1a and Mel1b receptors.
Nat.Neurosci. 2: 401-403, 1999.
Wang
JH and Kelly P. Calcium-calmodulin signalling pathway up-regulates glutamatergic
synaptic function in non-pyramidal, fast spiking rat hippocampal CA1 neurons.
J.Physiol 533: 407-422, 2001.
Wang
JH and Kelly PT. Postsynaptic injection of CA2+/CaM induces synaptic
potentiation requiring CaMKII and PKC activity. Neuron 15: 443-452, 1995.
Wang
JH and Kelly PT. Regulation of synaptic facilitation by postsynaptic Ca2+/CaM
pathways in hippocampal CA1 neurons. J.Neurophysiol. 76: 276-286, 1996a.
Wang
JH and Kelly PT. The balance between postsynaptic Ca(2+)-dependent protein
kinase and phosphatase activities controlling synaptic strength. Learn.Mem.
170-181, 1996b.
Wang
JH and Kelly PT. Attenuation of paired-pulse facilitation associated with
synaptic potentiation mediated by postsynaptic mechanisms. J.Neurophysiol. 78:
2707-2716, 1997.
Weaver
DR, Stehle JH, Stopa EG and Reppert SM. Melatonin receptors in human
hypothalamus and pituitary: implications for circadian and reproductive
responses to melatonin. J.Clin.Endocrinol.Metab 76: 295-301, 1993.
Webley
GE, Mehl H and Willey KP. Validation of a sensitive direct assay for melatonin
for investigation of circadian rhythms in different species. J.Endocrinol. 106:
387-394, 1985.
White
JA, Baxter DA, Byrne JH. Analysis
of the modulation by serotonin of a voltage-dependent potassium current in
sensory neurons of Aplysia. Biophys
J. 66:710-718, 1994.
Wiechmann
AF and Smith AR. Melatonin receptor RNA is expressed in photoreceptors and
displays a diurnal rhythm in Xenopus retina. Brain Res.Mol.Brain Res. 91:
104-111, 2001.
Wieraszko
A. Uptake of D-[3H]aspartic acid by hippocampal slices: the influence of low and
high frequency activation of nerve endings. Brain Res. 259: 324-326, 1983.
Wiesenberg
I, Missbach M, Kahlen JP, Schrader M and Carlberg C. Transcriptional activation
of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and
identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res. 23:
327-333, 1995.
Winczyk
K, Pawlikowski M and Karasek M. Melatonin and RZR/ROR receptor ligand CGP 52608
induce apoptosis in the murine colonic cancer. J.Pineal Res. 31: 179-182, 2001.
Wirz-Justice
A, Kafka MS, Naber D and Wehr TA. Circadian rhythms in rat brain alpha- and
beta-adrenergic receptors are modified by chronic imipramine. Life Sci. 27:
341-347, 1980.
Witt-Enderby
PA, Chu GH, Gillen ML and Li PK. Development of a high-affinity ligand that
binds irreversibly to Mel1b melatonin receptors. J.Med.Chem. 40: 4195-4198,
1997.
Witt-Enderby
PA and Li PK. Melatonin receptors and ligands. Vitam.Horm. 58: 321-354, 2000.
Won
JS, Song DK, Huh SO, Kim YH and Suh HW. Effect of melatonin on the regulation of
proenkephalin and prodynorphin mRNA levels induced by kainic acid in the rat
hippocampus. Hippocampus 10: 236-243, 2000.
Wu
FS, Yang YC and Tsai JJ. Melatonin potentiates the GABA(A) receptor-mediated
current in cultured chick spinal cord neurons. Neurosci.Lett. 260: 177-180,
1999.
Xiao
MY, Zhou Q and Nicoll RA. Metabotropic glutamate receptor activation causes a
rapid redistribution of AMPA receptors. Neuropharmacology 41: 664-671, 2001.
Xu
MF, Tang PL, Qian ZM and Ashraf M. Effects by doxorubicin on the myocardium are
mediated by oxygen free radicals. Life Sci. 68: 889-901, 2001.
Yu
HS, Pang SF, Tang PL and Brown GM. Persistence of circadian rhythms of melatonin
and N-acetylserotonin in the serum of rats after pinealectomy.
Neuroendocrinology 32: 262-265, 1981.
Yuan
H and Pang SF. [125I]melatonin binding sites in membrane preparations of quail
brain: characteristics and diurnal variations. Acta Endocrinol.(Copenh) 122:
633-639, 1990.
Zatz
M, Gastel JA, Heath JR III and Klein DC. Chick pineal melatonin synthesis: light
and cyclic AMP control abundance of serotonin N-acetyltransferase protein.
J.Neurochem. 74: 2315-2321, 2000.
Zawilska
JB and Nowak JZ. Melatonin: from biochemistry to therapeutic applications.
Pol.J.Pharmacol. 51: 3-23, 1999.
Zawilska
JB, Vivien-Roels B, Skene DJ, Pevet P, and Nowak JZ. Phase-shifting effects of
light on the circadian rhythms of 5- methoxytryptophol and melatonin in the
chick pineal gland. J.Pineal Res. 29:1-7, 2000.
Zeise
ML and Semm P. Melatonin lowers excitability of guinea pig hippocampal neurons in
vitro. J.Comp Physiol [A] 157: 23-29, 1985.
Zhang
Q and Zhang J. Effect of melatonin
on the spatial and temporal changes of [Ca2+ ]i in single
living cells of cortical neurons by laser scanning confocal microscopy. Chin Med
J 113:558-562, 2000.
Zhou
JJ, Esteban JA, Hayashi Y, Malinow R. Postnatal
synaptic potentiation: delivery of Glu4-containing AMPA receptors by spontaneous
activity. Nature Neurosci 3: 1098-1106, 2000.
Zhu
JJ, Esteban JA, Hayashi Y, and Malinow R. Postnatal synaptic potentiation:
delivery of GluR4-containing AMPA receptors by spontaneous activity.
Nat.Neurosci. 3: 1098-1106, 2000.
Zisapel
N and Laudon M. Inhibition by melatonin of dopamine release from rat
hypothalamus: regulation of calcium entry. Brain Res. 272: 378-381, 1983.
Zucker
RS. Short-term synaptic plasticity.
Ann Rev Neurosci 12: 13-31, 1989.
